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Foamy viruses (FV) are complex retroviruses with additional bel genes located between env and the 39 long-terminal
repeat. The functions of the bel 2 and bet genes are unknown and both are dispensable for replication of the prototypic
human foamy virus in cell cultures. We examined the function(s) of bel 2 and bet of the distantly related feline foamy virus
(FFV) in the proviral context. Mutagenesis was used to alter the Bel 2 and Bet or to abrogate their expression. The Bel 2/Bet
mutants showed a 1000-fold reduced viral titer in feline kidney cells; in human 293T cells, viral titer was only about 10-fold
reduced compared to wild-type FFV. In both cell types, the Bel 2/Bet mutations resulted in a reduced release of FFV particles.
The results indicate that FFV Bet is required for efficient virus replication. The functions of the Bel 2 and Bet proteins are
discussed. © 2001 Academic Press
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iINTRODUCTION
Spumaretroviruses or foamy viruses (FV) are retrovi-
ruses with a complex genome organization (Cullen, 1991;
Linial, 1999; Lo¨chelt and Flu¨gel, 1995; Rethwilm, 1995;
Lecellier and Saib, 2000). Important features of their
replication strategy and molecular biology appear to be
unique among the known retroviruses. This is best illus-
trated by the expression of Pol proteins from a spliced
transcript, the mode of Gag–Env interaction during viral
morphogenesis and budding, proteolytic processing of
Gag and Pol proteins, and defined aspects of reverse
transcription, genome integration, and gene expression
(Baldwin and Linial, 1998; Bodem et al., 1996; Enssle et
al., 1996; He et al., 1996; Heinkelein et al., 2000; Lo¨chelt,
2001; Lo¨chelt and Flu¨gel, 1996; Pfrepper and Flu¨gel,
2001; Pietschmann et al., 1999; Wilk et al., 2001, Yu et al.,
1996).
A hallmark of FVs is the efficient utilization of an internal
promoter (IP) to direct expression of the regulatory and
accessory bel genes located between env and the 39 long-
terminal repeat (LTR) (Lo¨chelt et al., 1993, Lo¨chelt, 2001).
The Bel 1 protein, also designated Tas for transactivator of
spuma virus, is the viral transcriptional transactivator for
LTR- and IP-derived gene expression (Keller et al., 1991;
Lo¨chelt et al., 1993; Mergia et al., 1990; Rethwilm et al., 1991;
ou and Luciw, 1996). Human foamy virus (HFV) Bel 1 is
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310ssential for viral replication and has the ability to specifi-
ally activate expression of defined human host cell genes
Baunach et al., 1993; Lo¨chelt et al., 1991; Wagner et al.,
000; Yu and Linial, 1993). Sparse data on the biological
unction of Bel 2 and Bet are available. Deletion of HFV Bel
and Bet have been reported to have either no effect or
nly to reduce the viral titer marginally, especially when
ell-free HFV transmission was assayed (Adachi et al.,
995; Baunach et al., 1993; Lee et al., 1994; Yu and Linial,
993). However, cells expressing the HFV Bet protein were
hown to be resistant to HFV superinfection and it is as-
umed that an early event during infection was blocked by
et (Bock et al., 1998).
Expression of HFV Bel 2 in infected cells is low and no
ata exist on its subcellular localization (Lo¨chelt et al.,
991). In contrast, Bet is highly expressed in infected cells
nd predominantly localized in the cytoplasm of infected or
ransfected cells (Lo¨chelt et al., 1991). Bet is generated by a
plice event fusing the N-terminal shared domain of Bel 1 to
he coding sequence of Bel 2 (Bodem et al., 1998; Muranyi
nd Flu¨gel, 1991). Since the Bel 2 start codon is down-
tream of the Bet splice acceptor, Bel 2 is fully contained in
et. Bet is expressed in naturally infected cats and primates
ince antibodies against Bet are consistently detectable
nd are considered to be of diagnostic value (Alke et al.,
000; Hahn et al., 1994). The mode of Bel 2/Bet expression
nd their genomic localization is conserved. The degree of
equence homology of Bel 2/Bet proteins is, however, low
mong known FVs (Renshaw and Casey, 1994; Tobaly-
apiero et al., 2000). Genomic RNA that lacks the bet intron
s reverse transcribed in FV-infected cells and this DNA has
een implicated in establishing a persistent infection (Saib
t al., 1993).
D, pFe
B2.
311FUNCTION OF FELINE FOAMY VIRUS bel 2 AND bet GENESTo investigate the role of the feline foamy virus (FFV)
bel 2/bet genes, specific mutations were introduced into
both genes in the context of the proviral genome. The
mutant phenotypes were analyzed in comparison to the
wild-type (wt) genome and Bet was shown to be essen-
tial for infectivity. Bet appears to be required for the
efficient release of viral particles. These studies are
essential to understand the biology of FVs in more detail
and to exploit FVs as novel vectors for gene therapy
applications (Hill et al., 1999).
RESULTS
Construction of proviral FFV Bel 2/Bet mutants
As described under Materials and Methods and summa-
rized in Fig. 1, defined mutations were introduced into the
FFV proviral DNA clone pFeFV-7 (Zemba et al., 2000) to
inhibit expression of Bet (mutant pFeFV-DSD) or Bel 2
(mutant pFeFV-DB2). Additional mutants served to shorten
Bel 2 and Bet (mutant pFeFV-BBtr) and to slightly alter the
Bel 2 and Bet proteins (mutant pFeFV-MCS). The mutations
were inserted in a way which did not or only slightly affect
the overlapping bel 1 gene (Fig. 1). To exclude detrimental
effects of the Bel 1 Gly32Ala substitution in clones pFeFV-
DSD and pFeFV-DBB, the FFV LTR luciferase (luc) reporter
construct (Winkler et al., 1997) was cotransfected with the
different FFV bel 2/bet mutants as source of the Bel 1
transactivator into CRANDELL feline kidney (CRFK) cells.
The Bel 1-mediated transactivation of luc expression
gene was comparable in wt and mutant proviruses 1 day
after transfection (p.t.) (data not shown).
Titer of proviral FFV Bel 2/Bet mutants
FIG. 1. Schematic presentation of the FFV Bel 2/Bet mutations introd
line) sequences are shown in the single-letter code. Mutated residues
boldface letters; the single mutation of Bel 1 is shown below the seque
sequences. An additional gap in Bel 2 and Bet is due to the mutation
underlining. Abbreviations used for the different proviral constructs: DS
pFeFV-DBB contains the mutations of clones pFeFV-DSD and pFeFV-DThe phenotypes of the different FFV bel 2/bet mutants
were analyzed in comparison to the parental clonepFeFV-7 by transfection into feline CRFK cells and human
293T cells. The viral titers were always determined from
cell-free culture supernatants using the FFV-FAB indica-
tor cells for titration (Zemba et al., 2000). Especially in
feline CRFK cells, the FFV bel 2/bet mutants showed a
severely reduced viral infectivity in comparison to the wt
proviral genome pFeFV-7. Mean average viral titers were
determined in at least three independent transfection
experiments into CRFK and 293T cells and are shown in
Figs. 2A and 2B, respectively. One day p.t., the mutant
proviruses showed about 10-fold reduced titers in CRFK
and 293T cells. During further incubation, the viral titer
increased in wt pFeFV-7-transfected CRFK (A) and 293T
cells (B). In contrast, the Bel 2/Bet mutants displayed
72 h p.t. into CRFK cells at least 1000-fold decreased titer
than with wt FFV. In 293T cells, infectivity of the mutants
increased by time but remained about 10-fold reduced
compared with the wild-type provirus. Serial passages of
the Bel 2/Bet mutants in CRFK and 293T cells resulted in
the complete loss of infectivity, pointing to an important
role of these proteins in FFV replication.
Bel 1 expression and Bel 1-mediated transactivation
was not impaired in any of the mutants as discussed
above since the intracellular level of the Bel 1-induced
b-galactosidase expression in individual FFV-FAB re-
porter cells was comparable in mutant and wt FFV-
infected cells. Thus, the reduced titer can be attributed to
the Bel 2/Bet mutations introduced.
Gene expression of proviral FFV Bel 2/Bet mutants in
293T cells
293T cells were transfected with the wt provirus and
to the proviral FFV genome. The FFV Bet (top line) and Bel 1 (bottom
alterations affecting Bet and Bel 2 are shown above the sequence in
sterisks mark translational stop codons. Dots represent the Bet intron
ones pFeFV-MCS and pFeFV-BBtr. The Bel 2 sequence is marked by
FV-DSD; DB2, pFeFV-DB2; MCS, pFeFV-MCS; BBtr, pFeFV-BBtr. Mutantuced in
and the
nces. A
s in clthe Bel 2/Bet deletion mutants and harvested 1 and 3
days p.t. Cell lysates were used for immunoblotting to
., cell-fr
our (A)
312 ALKE ET AL.determine the expression of viral proteins. To confirm the
phenotype of the mutants, FFV gene expression was
analyzed with an antiserum directed against Bel 2 and
Bet. In 293T cells, Bel 2 was unambiguously detectable 1
and 3 days p.t. of pFeFV-DSD DNA (Fig. 3A). It was,
however, not expressed by any of the other FFV DNA
clones and was also absent in FFV-infected CRFK cells
(data not shown). Bet was present in wt pFeFV-7 and
pFeFV-DB2-transfected 293T cells at comparable levels
(Fig. 3A), whereas it was absent in pFeFV-DSD-trans-
fected cells, as expected. The expression of FFV Bel 1
was analyzed in parallel and found to be identical in wt-
and pFeFV-DB2-transfected cells (Fig. 3B). Remarkably,
Bel 1 was strongly overexpressed in pFeFV-DSD-trans-
fected cells. Due to the inactivation of the Bet SD in
mutant pFeFV-DSD, Bel 1 (Fig. 3B) and Bel 2 protein (Fig.
3A) expression of this clone is likely increased at the
expense of Bet expression.
The expression of Gag and Pol as measured by im-
munoblotting was almost identical 3 days p.t. but re-
duced early after transfection of 293T cells with Bel
2/Bet-deleted proviruses compared with wt FFV DNA
(data not shown, see also Fig. 6A).
To study whether the relative ratios of the different
structural proteins of FFV were changed by the muta-
FIG. 2. Growth kinetics of wild-type and mutant FFV. Feline CRFK ce
the mutants pFeFV-DSD, pFeFV-DB2, and pFeFV-DBB. At 24 and 72 h p.t
determined by the FAB assay. The data shown reflect the average of ftions, radioimmunoprecipitation (RIPA) experiments of
transfected 293T cells were performed. Cells were la-beled 30–48 h after transfection with pUC18, pFeFV-7,
pFeFV-DSD, and pFeFV-DB2 DNAs. The corresponding
extracts were precipitated with the FFV-specific cat se-
rum 8014 (Alke et al., 2000) and analyzed by PAGE and
autoradiography (Fig. 3C). For the different FFV genomes
used, the relative ratios of the FFV Env and Pol precur-
sors and the p52 and p48 Gag proteins were roughly
identical, although some differences in overall FFV pro-
tein expression were detectable. In summary, overall FFV
gene expression in 293T cells appeared to be almost not
affected by the Bel 2/Bet mutations except for the alter-
ations in Bel 2 and Bet.
Gene expression of proviral FFV Bel 2/Bet mutants in
CRFK cells
Feline CRFK cells were transfected with the wt provi-
rus and the Bel 2/Bet deletion mutants. Cell lysates were
analyzed for FFV gene expression by immunoblotting
with serum of the experimentally FFV-infected cat 8014
(Alke et al., 2000). Gag and Pol protein expression of
clones pFeFV-DSD, pFeFV-DB2, and pFeFV-DBB was
slightly reduced early after transfection compared with
wt pFeFV-7-transfected CRFK cells (Fig. 4A, left-hand
lanes). Structural gene expression of clone pFeFV-7 was
nd human 293T cells (B) were transfected with pFeFV-7 (wt) DNA and
ee supernatants were collected from each culture and virus titers were
and six (B) independent experiments, respectively.lls (A) agreatly increased 3 days p.t. The Bel 2/Bet mutants
showed reduced Gag expression compared with the wt
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313FUNCTION OF FELINE FOAMY VIRUS bel 2 AND bet GENESclone and the level of Pol proteins was close to or even
below the detection limit in these cells (Fig. 4A, right-
hand lanes, see also Fig. 6B).
FIG. 3. FFV protein expression in transfected 293T cells. Immunoblot
analysis of FFV Bel 2/Bet (A) and Bel 1 (B) protein expression in 293T
cells transfected with plasmids pUC18, pFeFV-7 (wt), pFeFV-DSD, and
pFeFV-DB2. Transfected 293T cells were lysed 1 and 3 days p.t. and
cellular extracts were analyzed by immunoblotting with hyperimmune
sera directed against bacterially expressed Bel 2/Bet (A) and Bel 1 (B,
see Materials and Methods). The positions of molecular mass markers
are shown in kDa on the right-hand margin, and arrows on the left
indicate the detected FFV proteins. (C) RIPA analysis of 293T cells
transfected with plasmids pUC18, wt pFeFV-7, pFeFV-DSD, and pFeFV-
DB2. Transfected cells were radioactively labeled 30–48 h p.t. The
extracts were precipitated with the FFV cat serum 8014 (Alke et al.,
2000) and analyzed by autoradiography. The positions of molecular
mass markers and specifically precipitated FFV proteins are indicated.RIPA experiments using transfected CRFK cells did not
yield specific FFV protein bands due to the low transfec-
a
pFIG. 4. FFV gene expression in wt- and mutant-transfected and infected
CRFK cells. (A) Western blot analysis of FeFV protein expression in CRFK cells
transfected with pUC18, pFeFV-7, pFeFV-DSD, pFeFV-DB2, and pFeFV-DBB at
1 and 3 days p.t. Cell lysates were collected from each culture and analyzed
by immunoblotting with the FFV-specific cat serum 8014 (Alke et al., 2000).
olecular mass markers are shown in kDa in the right-hand margin. On the
eft-hand side, arrows indicate the detected FFV proteins. (B) In parallel, CRFK
ells were infected with cell-free supernatants of 293T cells transfected with
UC18 DNA or with each 105 FFU of wt pFeFV-7-, mutant pFeFV-DSD-, and
FeFV-BBtr-transfected 293T cells. Infected CRFK cells were labeled from 30
o 50 h p.i.; protein extracts were harvested and precipitated with cat serum
014. The position of marker proteins (Rainbow marker, high molecular range,
mersham) and specifically detected FFV proteins are indicated. (C),
orthern blot analysis of FeFV mRNA expression in CRFK cells transfected
ith pUC18 (lane 1), pFeFV-7 (lane 2), pFeFV-MCS (lane 3), pFeFV-BBtr
lane 4), and pFeFV-DSD (lane 5) 1 day p.t. Enriched mRNA samples were
nalyzed by Northern blotting using a probe located in the bet intron. The
osition of defined FFV transcripts is indicated at the right-hand margin.
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314 ALKE ET AL.tion efficiency obtained with CRFK cells. To circumvent
this problem, the recombinant plasmids were first trans-
fected into 293T cells. Cell-free supernatants were har-
vested 3 days p.t.; FFV viral titers were determined and
each 105 FFU was used to infect CRFK cells. The infected
RFK cells were labeled from 30 to 50 h p.i. Protein
xtracts were harvested and subjected to RIPA using the
FV-specific cat serum 8014 (Fig. 4B). Gag and Env pro-
ein expression was almost identical in wt- and mutant-
nfected cells using autoradiography (Fig. 4B) or phos-
horimaging (data not shown). As expected, Bet was
nly expressed by wt FFV.
To further investigate gene expression of wt and mu-
ant genomes, transfected CRFK cells were harvested 1
ay p.t. and poly(A)1 mRNAs were extracted and sub-
jected to Northern blotting using an FFV DNA probe
located within the Bet intron (Fig. 4C). All distinct classes
of FFV transcripts were expressed; only plasmid pFeFV-
DSD yielded increased amounts and additional mRNA
bands in the bel/bet RNA range, which may be the result
of alternative RNA processing due to the mutagenesis of
the bet SD sequence. Whereas the relative expression of
the different RNA species was invariant in wt pFeFV-7
and mutants pFeFV-MCS and pFeFV-BBtr, pol mRNA ap-
peared to be overexpressed in clone pFeFV-DSD. In
summary, gene expression of the FFV Bel 2/Bet mutants
was reduced in CRFK cells.
Transcomplementation of proviral FFV Bel 2/Bet
mutants
To confirm the specificity of the effects on viral infec-
tivity, the Bel 2/Bet mutants were cotransfected into
CRFK cells together with the Bet and Bel 2 expression
FIG. 5. Transcomplementation analysis of the Bel 2/Bet mutant FeFV-
cells together with the Bet expression vector pFFVBet and Bel 2 expre
parallel. Cell-free supernatants of each culture were collected 1 and 3 d
were taken from one of three independent experiments that showed svectors pFFVBet and pFFVBel2. Viral titers were ana-
lyzed 1 and 3 days p.t. Representative data for mutant apFeFV-MCS (Fig. 5) showed that part of the viral titer was
restored by providing Bet in trans. In contrast, coexpres-
sion of Bel 2 did not show a significant enhancement of
infectivity. The other FFV Bel 2/Bet mutants showed a
similar transcomplementation of infectivity by Bet (Table
1; data not shown).
Since coexpression of FFV Bet but not Bel 2 allowed
partial reconstitution of viral titers, we addressed the
question whether the mutations in Bet introduced in
some of the proviral clones (Fig. 1) were primarily re-
sponsible for the reduced viral titer observed. Thus, the
Bet Met75Thr substitution of clone pFeFV-DB2 and the
y FFV Bet and Bel 2. The deletion mutant was cotransfected into CRFK
ector pFFVBel 2. As control, the wt-clone pFeFV-7 was transfected in
. and the virus titers were measured by the FAB assay. The data shown
transcomplementation values.
TABLE 1
Transcomplementation of wt and bet/bel 2-Deleted FFV Proviruses
by wt and Mutant FFV Bet in CRFK Cellsa
DNAs
cotransfected
1 day after
transfection
3 days after
transfection
pFeFV-7
1 pUC18 6 3 102 3 3 105
1 pFFVBet 6 3 103 1 3 105
1 pFFVBet-M/T 9 3 102 3 3 105
1 pFFVBet-MCS 2 3 103 4 3 106
pFeFV-DBel2
1 pUC18 8 3 101 3 3 102
1 pFFVBet 5 3 102 1 3 104
1 pFFVBet-M/T 2 3 101 5 3 102
1 pFFVBet-MCS 7 3 101 3 3 102
pFeFV-DSD
1 pUC18 4 3 100 1 3 101
1 pFFVBet 5 3 102 4 3 103
1 pFFVBet-M/T 3 3 101 5 3 101
1 pFFVBet-MCS 6 3 101 3 3 101MCS b
ssion va Titers of transcomplementations were determined using FAB cells
nd are expressed as blue cell units/ml cell culture supernatant.
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315FUNCTION OF FELINE FOAMY VIRUS bel 2 AND bet GENESMCS alterations of clone pFeFV-MCS were introduced by
PCR into the wt FFV Bet expression plasmid pFFVBet.
The resulting clones pFFVBet-M/T and pFFVBet-MCS
and wt clone pFFVBet were used for transcomplemen-
tation of wt and Bel 2/Bet mutant proviruses (Table 1).
Neither wt Bet nor mutant Bet reproducibly altered infec-
tivity of the wt FFV provirus 1 or 3 days p.t.; the slight
increase seen with pFFVBet-MCS DNA was not detect-
able in additional experiments. This indicates that the
mutant Bet molecules used did not display a transdomi-
nant negative effect on wt Bet from pFeFV-7. As de-
scribed above, wt Bet consistently rescued part of the
titer of mutants pFeFV-DB2 and pFeFV-DSD. In contrast,
none of the mutant Bet proteins was able to
transcomplement the Bel 2 deletion clone pFeFV-DB2.
he Bet deletion clone pFeFV-DSD was strongly
ranscomplemented by wt Bet and the titer of this clone
as slightly increased even by both mutant Bet proteins.
In conclusion, the data suggest that the alterations
ntroduced into Bet and expressed from plasmids pFeFV-
B2 and pFeFV-MCS significantly contribute to the de-
ective phenotype of these mutants. Taking into account
hat coexpression of Bel 2 did not show a significant
ffect on the viral titer (Fig. 5), the phenotype of the Bel
/Bet mutants seems to be predominantly, if not exclu-
ively, determined by mutations in bet.
FV Bet does not alter LTR- and IP-directed gene
xpression
The FFV LTR promoter luc expression construct
Winkler et al., 1997) and a corresponding reporter plas-
mid of the IP were assayed for effects of Bet on the basal
and Bel 1-activated FFV gene expression. Both FFV luc
reporter plasmids were cotransfected with wt and mu-
tant FFV Bet expression plasmids pFFVBet, pFFVBet-
MCS, and pFFVBet-M/T into 293T cells either in the
presence or in the absence of an FFV Bel 1 expression
plasmid (Winkler et al., 1997). Coexpression of wt and
utant FFV Bet proteins did not show any significant
ffect on the basal and Bel 1-transactivated reporter
ene expression driven by either the LTR or the internal
romoter (data not shown). Similarly, Gag expression
as not affected if virions derived from Bel 2 and Bet
eletion clone pFeFV-DB2 were used to infect CRFK cells
ransiently expressing wt and mutant Bet proteins (data
ot shown).
elease of viral particles from proviral FFV Bel 2/Bet
utants
293T cells were transfected with pFeFV-7, pFeFV-DSD,
nd pFeFV-DB2 DNA. Three days p.t., aliquots of the cell
ulture supernatants were used to infect CRFK cells (see
elow) and the remainder was used to purify released
iral particles by centrifugation through a sucrose cush-
on. The release of FFV particles and FFV gene expres-sion of the transfected 293T cells were analyzed by
immunoblotting using cat antiserum 8014. FFV antigen
expression by plasmids pFeFV-DSD and pFeFV-DB2 was
slightly reduced compared to the wt FFV provirus (Fig.
6A, left-hand lanes). In contrast, the release of FFV par-
ticles from pFeFV-DSD- and pFeFV-DB2-transfected 293T
cells was reduced by a factor of 2 and 4 compared with
wt-transfected cells (right-hand lanes). This indicates
that antigen expression of the mutants is only slightly
decreased, whereas release of mutant particles is about
two to four times lower.
Equal aliquots of the cell culture supernatants of the
transfected 293T cells described above were used to
infect CRFK cells. Three days p.i., cell-associated antigen
and released virus particles were analyzed as above.
Gene expression of the mutants as measured by analyz-
ing cell-associated antigen was reduced 10-fold for
pFeFV-DSD-infected and more than 20-fold for pFeFV-
FIG. 6. Analysis of particle release from transfected 293T cells (A)
and infected CRFK cells (B). In (A), cells were harvested 3 days p.t. and
regular aliquots were subjected to immunoblotting with FFV cat serum
8014 (left-hand lanes). Part of the cell-free culture supernatant was
used to purify the released viral particles, lysed and analyzed by
immunoblotting in parallel (right-hand lanes). In (B), aliquots of the
cell-free supernatants of 293T cells transfected with pFeFV-7, pFeFV-
DSD, and pFeFV-DB2 used in (A) were inoculated on CRFK cells.
Cellular antigen and released viral particles were harvested 3 days p.i.,
as described above and analyzed by immunoblotting with serum of
FFV-infected cat 8014. To facilitate the comparison of protein amounts,
extracts from plasmid pFeFV-7 were diluted 1:5 and 1:20, as indicated
above the blots. Molecular mass markers are shown in kDa on the
right-hand margin. On the left-hand side, the detected FFV proteins are
indicated.DB2-infected CRFK cells in comparison to the wt-infected
cells (Fig. 6B, left-hand lanes). In contrast, the release of
A
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316 ALKE ET AL.particles from pFeFV-DSD-infected CRFK cells was more
than 20-fold reduced and the release of virions from
pFeFV-DB2-infected CRFK cells was at least 50-fold re-
duced in comparison to the release of wt FFV particles.
When the release of particles is normalized to the differ-
ent levels of intracellular FFV antigen expression, the
amount of Bel 2/Bet mutant particles in the supernatant
shows an about two- to fourfold decrease when com-
pared with the wt FFV genome. When virions released
from wt and mutant FFV-infected CRFK cells described in
Fig. 4B were subjected to RIPA assays 2 days p.i., Gag
specific bands were only detectable in wt and not in
FIG. 7. Electron micrographs of thin sections of 293T cells transfe
ccumulated preassembled capsids in pFeFV-7 wt transfected cells. (B
ell membrane containing viral spike proteins (arrowhead in the inset)
ark preassembled capsids. In pFeFV-DSD-transfected cells (C), only p
etected; budding particles were not detectable. (D) Magnification of
epresent 400 and 100 nm, respectively.mutant-infected cells, although the initial titer and the
intracellular gene expression were comparable. In sum-mary, the data demonstrate that the release of Bel 2/Bet
mutant FFV particles was reproducibly decreased about
two- to fourfold compared to wt particles.
Electron microscopy of Bet/Bel 2-deleted FFV
To explore whether Bet has any effect on particle
morphology and assembly, 293T cells were transfected
with wt pFeFV-7 DNA and the mutant pFeFV-DSD. Two
days p.t., cells were washed, fixed, and processed for
thin-section electron microscopy. 293T cells transfected
with pFeFV-7 DNA contained arrays of preassembled
ith wt pFeFV-7 (A and B) and pFeFV-DSD (C and D) 2 days p.t. (A)
ng of capsids (black arrow) into the extracellular space (bottom) at the
ly observed in cells transfected with pFeFV-7 DNA. The white arrows
mbled capsids (boxed space), here in the vicinity of a Golgi-stack, were
ed space in (C) with preassembled capsids (white arrows). The barscted w
) Buddi
was on
reassecapsids in the cytoplasm in the vicinity of the Golgi
apparatus, as known for FVs including FFV (Fig. 7A;
t
f
i
d
i
b
m
w
w
p
m
p
t
i
d
B
t
i
c
t
o
t
b
2
i
d
r
s
i
r
s
n
r
t
F
d
m
s
s
t
(
e
D
j
c
t
c
317FUNCTION OF FELINE FOAMY VIRUS bel 2 AND bet GENESZemba et al., 1998). Budding of these particles consis-
ently occurred at the plasma membrane in areas with
inger-like membrane extrusions (Fig. 7B). Budding into
ntracellular membrane compartments was almost not
etectable. Preassembled capsids were also detectable
n mutants pFeFV-D SD (Figs. 7C and 7D); however,
udding of these particles through intra- or extracellular
embranes was not observed. In 293T cells transfected
ith pFeFV-DB2 DNA, budding of preassembled capsids
as detectable (data not shown).
Whereas FFV particles were reproducibly detected in
FeFV-7-transfected CRFK cells, virus particles were al-
ost undetectable in CRFK cells transfected with bet/bel
2 mutant proviruses.
DISCUSSION
The severe, about 1000-fold reduction in titer of FFV
genomes containing mutations in the bel 2/bet genes in
ermissive CRFK cells indicates that at least one of
hese genes is required for productive replication. This is
n contrast to HFV, where different Bel 2/Bet mutations
id not show a defined phenotype (Adachi et al., 1995;
aunach et al., 1993; Lee et al., 1994) or resulted in less
han 10-fold reduced HFV titer detectable only late after
nfection (Yu and Linial, 1993). Since the authentic target
ells of FVs are not known at present, it is possible that
he HFV bel 2/bet gene may be required for replication in
ther cell types or cells of other origin. The specificity of
he decrease in titer of our FFV mutants was confirmed
y rescue of a substantial part of the infectivity of the Bel
/Bet mutants by coexpression of wt FFV Bet. Surpris-
ngly, Bel 2 did not significantly transcomplement bel 2
eleted pFeFV-DB2, whereas this clone was partially
escued by coexpression of wt Bet. Therefore, we as-
ume that the Bet Met75Thr substitution and not the
nactivation of Bel 2 expression in clone pFeFV-DB2 was
esponsible for the reduced infectivity of this clone. Con-
istent with this suggestion, mutant Bet Met75Thr was
ot capable of transcomplementing pFeFV-DB2 and the
emaining mutants. Taken together with the observation
hat Bel 2 has not been unambiguously identified in
FV-infected CRFK cells except when the Bet splice
onor had been deleted (Fig. 3A), it is likely that the
odification and/or deletion of Bet was primarily respon-
ible for the phenotypes observed.
Taking into account that mutagenesis of Bet was re-
ponsible for the reduced infectivity, it was surprising
hat not only the complete abrogation of Bet expression
pFeFV-DSD), but also truncation of Bet (pFeFV-BBtr), and
ven subtle modification of its primary sequence (pFeFV-
B2, pFeFV-MCS) displayed similar phenotypes as
udged by viral titer and transcomplementation. For
lones pFeFV-DB2 and pFeFV-MCS that contain Bet mu-ations at residues 75 and 117–119, it is reasonable to
onclude that the integrity of this region of Bet may berequired for proper folding and secondary or even ter-
tiary structure. Using the DSC secondary structure pre-
diction program (King et al., 1997), the Met75Thr substi-
tution completely abolished an extended b-sheet in FFV
Bet that appears to be also present in the equine and
bovine FV Bet proteins (data not shown).
The different titers and kinetics of FFV antigen expres-
sion of wt pFeFV-7 and the Bel 2/Bet mutants in CRFK
and 293T cells may be due to the full permissiveness of
CRFK cells for FFV. In contrast, infection of 293T cells
with FFV particles is inefficient (unpublished observa-
tions), whereas transfection of 293T cells is much more
efficient than that of CRFK cells. Thus, 293T cells may
reflect the infectivity and gene expression of the input
proviral DNA even late after transfection. CRFK cells
infected with identical titers of wt and mutant particles
showed a similar level of gene expression 2 days p.i.,
whereas the differences in viral titer of transfected pro-
viruses had been further multiplied by additional rounds
of replication 3 days p.t. However, this interpretation
does not rule out cell type specific differences of Bel
2/Bet proteins for FFV replication.
The reduced titer is a consistent trait of the Bel 2/Bet
mutants described here. The question remains as to
which viral function(s) had been affected by the muta-
tions. The data on the release of FFV particles and those
obtained by thin-section EM suggest that budding and
release of particles are affected (Figs. 6 and 7). Whereas
assembly of cytosolic capsid appeared not to be altered,
budding of FFV particles through cellular membranes
was not detectable in the Bet deletion mutant pFeFV-
DSD. In contrast, wt FFV budded primarily at the plasma
membrane. However, particle release was only reduced
in the Bet mutant since FFV antigens were released into
the cell culture supernatants and FFV infectivity was
detectable. This implies that alternative pathways for
virus release may have been used by the Bet mutant or
that “typical” budding intermediates were no longer de-
tectable. In clone pFeFV-DB2 encoding the Bet Met75Thr
mutation, typical budding structures were observed.
However, it is unlikely that the about two- to fourfold
reduced release of particles solely accounts for the
strong differences in titer detected in CRFK cells. It is
thus also likely that the infectivity of these mutant parti-
cles is compromised, which may be related to budding-
related defects in assembly and morphogenesis.
A reduced release of HFV Bel 2/Bet mutant particles
very late after infection of human cells has been de-
scribed by Yu and Linial (1993) and is fully consistent
with the data reported here. The observation of Bock et
al. (1998) that HFV Bet-expressing cells are resistant to
HFV superinfection also does not contradict our obser-
vations. It is conceivable that Bet that is involved in the
release of particles may also interfere with the uptake of
virus particles since release and uptake may share com-
mon components.
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318 ALKE ET AL.We cannot rule out the possibility that Bel 2 and/or Bet
are additionally involved in other steps of FV replication.
For instance, Bel 2 or Bet may modulate viral transcrip-
tion under certain circumstances and/or the utilization of
defined transcripts for FV gene expression (Linial, 2000).
However, data supporting such an additional function
have not been obtained in this study. Further studies are
required to fully determine the functions of the FFV Bel
2/Bet proteins in cell cultures and infected cats and to
establish why these proteins are apparently almost dis-
pensable in HFV.
MATERIALS AND METHODS
Virus and cells
FFV strain FUV7 has been described previously and
was propagated in CRFK cells (Flower et al., 1985;
Winkler et al., 1997). FFV infections were always per-
ormed with released, cell-free virus. FFV-FAB titration
ells were selected and maintained in CRFK cell medium
upplemented with 500 mg/ml G418 (Roche, Mannheim,
ermany). FFV titer was assayed using FFV-FAB cells
rown in 24-well plates (Zemba et al., 2000). DNA trans-
fection into CRFK cells was performed by electroporation
and for 293T cells; the calcium coprecipitation method
was used as described previously (Wagner et al., 2000;
Zemba et al., 2000).
Construction of proviral FFV bel 2/bet mutants
The different FFV Bel 2/Bet mutants are schematically
presented in Fig. 1.
pFeFV-MCS. To change defined amino acid residues
in Bel 2/Bet and to introduce unique restriction enzyme
sites into the infectious FFV clone pFeFV-7 (Zemba et al.,
2000), the bel 2 gene was amplified by PCR with primers
located at nt positions 9029 (59-TTCACGAAGGAGACTATC-
CAGAGT-39) and 9809 (59-CCGGTACCGGTCCGCGGCG-
TACGCTAGCTCTAGTTAGCATAGTCAAATCCC-39) using Pfu
DNA polymerase as recommended by the supplier (Strat-
agene, Heidelberg, Germany). The underlined sequence
of the antisense primer contains recognition sites for
NheI, BsiWI, SacII, AgeI, and KpnI. The Bel 2 sequence
Glu43-Leu44-Leu44 was altered to AlaSerValArgArg-
GlyPro, corresponding to Bet residues 117–119. The re-
sulting amplicon of about 800 bp was subcloned into
pCR2.1TOPO (Topo Cloning Kit, Invitrogen). The FFV in-
sert was excised with BspEI and KpnI and cloned into the
infectious FFV clone pFeFV-7 in a three-component liga-
tion. Recombinant clone pFeFV-MCS and all other mu-
tants described below were thoroughly analyzed by re-
striction-enzyme digestion and the inserted alterations
were confirmed by DNA sequencing.
pFeFV-BBtr. The bel 2/bet genes of clone pFeFV-MCS
were truncated directly downstream of the bel 1 gene. To
this end, pFeFV-MCS was digested with NheI and AgeI,
T
wwhich both cut in the mutated sequence. The ends of the
linearized vector were blunt-ended with Klenow DNA
polymerase and religated. This resulted in a frameshift
(11) at nt position 9876 fusing the heterologous residues
AlaSerArgTyrGlnGlu to the N-terminal 42 residues of Bel
2 and to the N-terminal 116 residues of Bet.
pFeFV-DSD. To specifically abolish Bet expression, the
SD in bel 1 required to generate Bet-encoding transcripts
by splicing (Bodem et al., 1998) was specifically de-
troyed by ligation PCR. Two independent PCRs
ere performed with primers located at nt positions 7163
59-CCAATTGGACAAGAGTAGAATCCTATGG-39) and 9291
59-ATTCGCTGACGTCAGGTCCAATCCAGAAGTGGAAT-
GAGT-39) and with primers at positions 9672 (59-
CTTCTTGATAGTCGCTTCGG-39) and 9310 (59-GATTG-
ACCTGACGTCAGCGAATAAAGAAGAACCTTTGAT-39);
he mutations introduced are in boldface letters. Plasmid
FeFV-7 (Zemba et al., 2000) served as template as
efined above. Subsequently, the two amplicons served
s template using the external primers at positions 7163
nd 9672, leading to a fused PCR product of 2.5 kb,
hich contained the mutation from GT to CG in the bet
D and an additional inserted AatII site (underlined). In
he overlapping bel 1 reading frame, the SD mutation led
o a Gly32Ala substitution, whereas the other mutations
ere silent. The 2.5-kb PCR product was digested with
mlI and BspEI and inserted into the correspondingly
igested plasmid pFeFV-7, resulting in DNA clone pFeFV-
SD.
pFeFV-DB2. As described for mutant pFeFV-DSD, the
el 2 AUG start codon in plasmid pFeFV-7 was specifi-
ally deleted. PCR primers located at nt positions 8490
59-GAATGCAGGATATTTATCTAAGG-39) and 9724 (59-GC-
GTTACATACG-GATTCA-39) and located at nt positions
983 (59-GCATCACAATCTGGGTCGG-39) and 9724 (59-
TGAATCCGTATGTAACGGC-39) were used. The altered
esidues are shown in boldface letters. In the resulting
CR product of about 1.5 kb, the bel 2 ATG start codon
as changed to ACG. The mutation did not affect Bel 1
ut led to the Met75Thr substitution in Bet. The PCR
roduct was digested with BsaAI and KpnI and inserted
nto the corresponding sites of pFeFV-7, resulting in
lone pFeFV-DB2.
pFeFV-DBB. The mutant pFeFV-DB2, which has the
SD and the DB2 phenotype, was constructed in analogy
o plasmid pFeFV-DB2 using pFeFV-DSD DNA as tem-
late for PCR amplification.
onstruction of eukaryotic Bel 2 expression plasmid
The coding sequences of the FFV bel 2 gene was
mplified by PCR as described above using pFeFV-7
emplate DNA and primers at nt positions 9716 (59-CAG-
AAGCTT-CCAATTCTGAGTCCGT-39) and 10,686 (59-CA-
AATCCAGGTAAATTCAG-39). A HindIII site (underlined)
as included in the sense primer. The PCR product was
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319FUNCTION OF FELINE FOAMY VIRUS bel 2 AND bet GENESdigested with HindIII and inserted into the HindIII- and
SmaI-digested pBC12CMV DNA (Sambrook et al., 1989).
The corresponding expression plasmid was designated
pFFVBel2 and directed the expression of the 33-kDa Bel
2 protein. The corresponding FFV Bet expression plas-
mid has been described previously (Alke et al., 2000).
Construction of mutant FFV Bet expression plasmids
The alterations of Bet in proviral clones pFeFV-MCS
and pFeFV-DB2 were introduced into the FFV Bet expres-
sion plasmid pFFVBet (Alke et al., 2000). The BspEI–XbaI
fragment of plasmid pFFVBet was replaced by the cor-
responding DNA fragments of the clones pFeFV-MCS
and pFeFV-DB2. The identities of the clones pFFVBet-
MCS and pFFVBet-M/T were analyzed by restriction-
enzyme digestion and Bet protein expression was con-
firmed by transfection into eukaryotic cells and immuno-
blotting.
Immunoblotting and RIPA
Cells were harvested 2 days after transfection by lysis
in 1% SDS and the protein concentration was determined
using the DC protein assay (Bio-Rad, Munich, Germany).
Identical amounts of proteins were separated by SDS–
PAGE, blotted, reacted with different FFV-specific sera
directed against recombinant proteins or a cat hyperim-
mune serum, and detected as previously described (Alke
et al., 2000). Labeling of cells and radioimmunoprecipi-
tation were done as described (Alke et al., 2000).
Northern blotting
Extraction of RNA from transfected CRFK cells,
poly(A)1 selection, and Northern blotting were done as
escribed (Wagner et al., 2000). A PCR-amplified FFV
DNA fragment located in the bet intron (FFV nt 9323–
534) was used as described (Bodem et al., 1998).
uc expression assays
The FFV LTR luc reporter plasmid has been described
reviously (Winkler et al., 1997) and a corresponding FFV
P-based construct will be described elsewhere. Luc
eporter assays were performed and quantified as de-
cribed. Each 2 mg of the reporter plasmids and each 2
mg of a Bel 1/Bet expression plasmid or the wt and
mutant FFV proviruses were transfected (Winkler et al.,
1997). Luc expression was measured using a Lumino-
skan TL Plus luminometer (Labsystems, Frankfurt, Ger-
many). Luc values were normalized according to coex-
pressed b-gal activity, which was comparable in the
different samples. As controls, the pGL2-promoter vector
backbone was analyzed and found to be slightly acti-
vated by Bel 1. These values were routinely subtracted
from those derived from FFV LTR- and IP luc reporter
plasmids.Transmission electron microscopy
Electron microscopy was done with minor modifica-
tions as described (Zemba et al., 1998). In brief, trans-
fected 293T cells grown on glass coverslips were gently
washed with PBS 2 days p.t. and fixed for 60 min with 4%
formaldehyde and 0.25% glutaraldehyde in PBS. Subse-
quently, the cells were washed with PBS and postfixed
with 1% osmium tetroxide in water for 60 min. After
washing two times, the specimens were dehydrated in a
graded ethanol series. The 70% step was supplemented
with 2% uranyl acetate and cells were stained for 60 min
in the dark. Dehydrated cells were then embedded in
Epon 812. After polymerization, the glass coverslips were
removed in 20% hydrogen fluoric acid for ;60 min. Ul-
trathin sections were made perpendicular to the cell
layer with a diamond knife on a Leica Ultracut UCT,
doubly stained with uranyl acetate and lead citrate, and
analyzed using a Philips BioTwin CM120 electron micro-
scope.
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